The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

While your healthcare provider can use an endoscopy to test for both Crohn's disease and ulcerative colitis, they look for certain signs that can detect the difference between both conditions.

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

So we have many different medications that work to treat ulcerative colitis. We break them down into different categories and also for different indications. So we have some agents that work ...

Omvoh demonstrated 53% clinical remission and 46% endoscopic response in Crohn's patients after one year ... first-in-class ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

It was a day to see some big names take the pitch in a father vs son football match and also learn more about the effects of ...